You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Novel Drug Combinations

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer Trial in Worldwide (AZD2936, MEDI5752, FOLFOX)

Recruiting
  • Gastric Cancer
  • Beijing, China
  • +25 more
Jan 18, 2023

Multiple Myeloma Trial in Leicester (CC-92480, Tazemetostat, BMS-986158)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +9 more
Oct 24, 2022

2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial in Miami (Famotidine, Celecoxib,

Active, not recruiting
  • 2019 Novel Coronavirus Disease
  • +11 more
  • Miami, Florida
    US02-04: Integrated Health Solutions
Aug 15, 2022

Multiple Myeloma Trial in Boston (BMS-986393, Alnuctamab, Mezigdomide)

Not yet recruiting
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
Nov 2, 2023

Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer Trial (Zimberelimab (ZIM), Domvanalimab (DOM), Sacituzumab

Not yet recruiting
  • Lung Cancer
  • Advanced or Metastatic Non-Small-Cell Lung Cancer
  • Zimberelimab (ZIM)
  • +9 more
  • (no location specified)
Nov 21, 2022

Pain, Postoperative Trial in Taipei City (Naldebain, SafeTynadol, Naldebain + SafeTynadol)

Not yet recruiting
  • Pain, Postoperative
  • Taipei City, Beitou District, Taiwan
    Taipei Veterans General Hospital
May 3, 2023

Colon Carcinoma Trial in Netherlands (Nivolumab, Ipilimumab, Celecoxib 200mg)

Recruiting
  • Colon Carcinoma
  • Amsterdam, Netherlands
  • +5 more
Jan 23, 2023

Lung Cancer, Non-Small Cell Trial in Worldwide (Pembrolizumab, Dostarlimab, GSK4428859A)

Recruiting
  • Lung Cancer, Non-Small Cell
  • Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
  • +14 more
Dec 26, 2022

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))

Not yet recruiting
  • Renal Cell Carcinoma
  • +2 more
  • Implantable Microdevice (IMD)
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 17, 2023

Newly Diagnosed Glioblastoma Trial (combinations of up to 3 FDA approved drugs from a panel of compounds)

Not yet recruiting
  • Newly Diagnosed Glioblastoma
  • combinations of up to 3 FDA approved drugs from a panel of compounds
  • (no location specified)
Jan 19, 2023

Metastatic Castration-resistant Prostate Cancer Trial in United States (drug, radiation, device)

Completed
  • Metastatic Castration-resistant Prostate Cancer
  • NKTR-214 (Cohort A)
  • +6 more
  • Los Angeles, California
  • +5 more
Nov 10, 2022

Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (CC-122, CC-223, Rituximab)

Active, not recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Santa Barbara, California
  • +22 more
Jan 25, 2023

Substance Use, Harm Reduction, Adolescent Behavior Trial in Boston (iDECIDE)

Not yet recruiting
  • Substance Use
  • +2 more
  • iDECIDE
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 30, 2023

Myeloma Novel Drug Discovery Ver 1.2

Recruiting
  • Multiple Myeloma
  • Observational study - sample collection only.
  • London Borough of Sutton, United Kingdom
    The Royal Marsden NHS Foundation Trust
Aug 1, 2023

Ovarian Tumors Trial in Canada, Spain, United States (Niraparib, TSR-042, Bevacizumab)

Recruiting
  • Ovarian Neoplasms
  • Birmingham, Alabama
  • +24 more
Dec 9, 2022

Cystic Fibrosis, Cystic Fibrosis Liver Disease, Cystic Fibrosis in Children Trial in Ireland, United Kingdom (Kaftrio)

Recruiting
  • Cystic Fibrosis
  • +4 more
  • Dublin, Leinster, Ireland
  • +6 more
May 3, 2022

Aims to Assess Consistency of Clinical Efficacy in Gastric

Recruiting
  • Gastric Cancer
  • Organoids
    • Shenyang, Liaoning, China
      Phase I Clinical Trials Center Of The First Hospital of China Me
    Oct 20, 2023

    Aims to Assess Consistency of Clinical Efficacy in Colorectal

    Recruiting
    • Colorectal Cancer
    • Organoids
      • Shenyang, Liaoning, China
        Phase I Clinical Trials Center Of The First Hospital of China Me
      Oct 20, 2023

      Pharmacometrics to Advance Novel Regimens for Drug-resistant

      Recruiting
      • Multi-drug Resistant Tuberculosis
        • Almaty, Kazakhstan
        • +6 more
        Nov 1, 2022

        Adenoid Cystic Carcinoma, Adenoid Cystic Carcinoma of the Salivary Gland Trial in Boston (Implantable Microdevice (IMD))

        Not yet recruiting
        • Adenoid Cystic Carcinoma
        • Adenoid Cystic Carcinoma of the Salivary Gland
        • Implantable Microdevice (IMD)
        • Boston, Massachusetts
        • +1 more
        Sep 22, 2022

        Impacted Third Molar Tooth, PAIN Trial in Harare (diclofenac / acetaminophen /codeine, ibuprofen/acetaminophen/codeine)

        Suspended
        • Impacted Third Molar Tooth
        • PAIN
        • Harare, Zimbabwe
          Dr Silas bere
        Jan 4, 2023

        MDS Trial in Worldwide (MBG453, NIS793, canakinumab)

        Recruiting
        • Myelodysplastic Syndromes
        • Duarte, California
        • +14 more
        Jan 23, 2023

        Novel Antidiabetic Drug Combined With Angiotensin

        Recruiting
        • Type 2 Diabetes
        • Antidiabetic Drugs
          • Beijing, Beijing, China
          • +1 more
          Jun 20, 2023

          Sciatica Acute, Sciatica Trial in Rawalpindi (Lacosamide 50 MG Oral Tablet [Vimpat], Codeine Phosphate, Diclofenac Sodium)

          Completed
          • Sciatica Acute
          • Sciatica
          • Lacosamide 50 MG Oral Tablet [Vimpat]
          • +2 more
          • Rawalpindi, Punjab, Pakistan
            Mehreen Mirza
          Nov 15, 2022

          Borderline Personality Disorder Trial in Melbourne (NMDA receptor antagonist (active drug), Lactose packed capsule

          Recruiting
          • Borderline Personality Disorder
          • NMDA receptor antagonist (active drug)
          • Lactose packed capsule (inert/inactive arm)
          • Melbourne, Victoria, Australia
            Monash Alfred Psychiatry Research Centre
          Sep 27, 2022